Last update 25 May 2025

Atorvastatin/Hydrochlorothiazide/Aspirin/Valsartan

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Atorvastatin Calcium/Hydrochlorothiazide/Aspirin/Valsartan, PolyPill 4-2
Target
AT1R x COXs x HMGCR x NCC
Action
antagonists, inhibitors
Mechanism
AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), COX inhibitors(Cyclooxygenases inhibitors), HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors)
Therapeutic Areas
Cardiovascular Diseases
Active Indication-
Inactive Indication
Cardiovascular Diseases
Originator Organization-
Active Organization-
Inactive Organization
Tehran University of Medical SciencesTehran University of Medical Sciences
License Organization-
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC24H29N5O3
InChIKeyACWBQPMHZXGDFX-QFIPXVFZSA-N
CAS Registry137862-53-4
View All Structures (4)

Related

1
Clinical Trials associated with Atorvastatin/Hydrochlorothiazide/Aspirin/Valsartan
NCT01271985
/ CompletedPhase 3IIT
Fixed-dose Combination Therapy (PolyPill) in Primary and Secondary Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians
100 Clinical Results associated with Atorvastatin/Hydrochlorothiazide/Aspirin/Valsartan
Login to view more data
100 Translational Medicine associated with Atorvastatin/Hydrochlorothiazide/Aspirin/Valsartan
Login to view more data
100 Patents (Medical) associated with Atorvastatin/Hydrochlorothiazide/Aspirin/Valsartan
Login to view more data
100 Deals associated with Atorvastatin/Hydrochlorothiazide/Aspirin/Valsartan
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Cardiovascular DiseasesPhase 3
United States
Tehran University of Medical SciencesTehran University of Medical Sciences
01 Feb 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free